Clinical trials
Completed Lymphadenopathy trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 1 |
| 2003 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 1 |
| 2012 | 4 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 1 |
| 2018 | 2 |
| 2021 | 2 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 29 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 4 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 3 |
| Far Eastern Memorial Hospital | 2 |
| Massachusetts General Hospital | 2 |
| University College Hospital Galway | 2 |
| Chimei Medical Center | 1 |
| Chinese PLA General Hospital | 1 |
| City of Hope Medical Center | 1 |
| Emory University | 1 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphadenopathy | 29 |
| Lung Neoplasms | 5 |
| Splenomegaly | 4 |
| Autoimmune Lymphoproliferative Syndrome | 3 |
| Breast Neoplasms | 3 |
| Fever | 3 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 |
| Lymphocytosis | 3 |
| Lymphoproliferative Disorders | 3 |
| Thrombocytopenia | 3 |
Trials
Showing 51 to 29 of 29. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.